Company Filing History:
2 out of 9 
2 out of 13 
1 out of 44 
Years Active: 2013-2019
Title: The Innovative Contributions of Gerhard Koenig
Introduction
Gerhard Koenig is a notable inventor based in Newton, MA, who has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, he has focused on developing compounds that enhance cognitive function.
Latest Patents
One of his latest patents is titled "Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotinic acetylcholine receptors." This invention relates to novel geminal substituted quinuclidine amide compounds and their pharmaceutical compositions, which are suitable as agonists or partial agonists of α7-nAChR. The patent outlines methods for preparing these compounds and compositions, as well as their use in maintaining, treating, and improving cognitive function. Specifically, it describes methods for administering the compound or composition to patients with cognitive deficiencies or those seeking to enhance cognitive function.
Career Highlights
Throughout his career, Gerhard Koenig has worked with various companies, including Forum Pharmaceuticals, Inc. and Envivo Pharmaceuticals, Inc. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Gerhard has collaborated with notable individuals in the field, including Richard Chesworth and Gideon Shapiro. These collaborations have contributed to the success of his innovative projects.
Conclusion
Gerhard Koenig's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in the realm of cognitive enhancement. His patents and collaborations highlight his commitment to improving cognitive function through scientific advancements.